Similar articles

• A comparison of propranolol and prindolol in the treatment of essential hypertension.

  Beaton GR, Rosendorff C, Kramer R, Simpson RD. Beaton GR, et al. Curr Ther Res Clin Exp. 1974 Apr;16(4):268-74. Curr Ther Res Clin Exp. 1974. PMID: 4208340 Clinical Trial. No abstract available.
• [Efficacy of treatment with inderal and visken of patients with circulatory insufficiency].

  Shevchenko IA, Marchenko AM, Simonenko VB. Shevchenko IA, et al. Voen Med Zh. 1983 Feb;(2):51-3. Voen Med Zh. 1983. PMID: 6133395 Russian. No abstract available.
• Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.

  Kirch W, Axthelm T. Kirch W, et al. Int J Clin Pharmacol Res. 1983;3(2):89-93. Int J Clin Pharmacol Res. 1983. PMID: 6148312 Clinical Trial.
• [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].

  Lil'in ET, Vavilova TA, Mar'in MI. Lil'in ET, et al. Klin Med (Mosk). 1983 Sep;61(9):85-9. Klin Med (Mosk). 1983. PMID: 6139506 Review. Russian. No abstract available.
• Pindolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.

  Golightly LK. Golightly LK. Pharmacotherapy. 1982 May-Jun;2(3):134-47. doi: 10.1002/j.1875-9114.1982.tb04521.x. Pharmacotherapy. 1982. PMID: 6133267 Review.